Marc Shenouda
Toronto, Ontario
Position: CEO & Co-Founder
Organization: Neuropeutics Inc
Nearly a decade of drug development expertise in neurodegeneration
Areas of Expertise:
Language(s):
My Work
What I do:
I am the CEO and Co-Founder of Neuropeutics Inc, a pharmaceutical company developing targeted therapies to extend neurodegenerative disease patients’ survival and improve their quality of life. I hold a PhD in Laboratory Medicine and Pathobiology with a Collaborative Program in Neuroscience from the University of Toronto, where I also completed his HBSc in Molecular Biology and Biotechnology, and Psychology. Throughout my academic and professional career, I have been recognized with numerous national and international awards and grants. Notably, I represented Neuropeutics as the only Canadian early stage venture in the Entrepreneurship World Cup 2024. My extensive research experiences and entrepreneurial initiatives have positioned me as an upcoming leader in the field of neurodegenerative disease therapeutics.
About Me
Sector: Industry
English proficiency: Read, Write, Speak
French proficiency: Read, Write, Speak
Other Language(s): Arabic
Title: Dr.
Pronouns: He/Him/His
Gender: Male